Cellular Hypoxia, orchestrated by the delicate interplay between cellular demands and oxygen availability, serves as a gateway to understanding essential aspects of cellular survival and adaptation. This intricate phenomenon orchestrates a symphony of responses, stretching its influence across diverse contexts including metabolic regulation, inflammation, and tissue regeneration. 

Impact Across Health and Disease:

Informed by the latest strides in cellular biology, exemplified by the pervasiveness of Cellular Hypoxia becomes abundantly clear. Its imprint extends through developmental biology, neurological disorders, cardiovascular diseases, and the intricate landscape of cancer progression. The dynamic interplay between oxygen availability and cellular function weaves a narrative that intricately shapes cellular destinies, leaving an indelible mark on both health and disease. This interconnection underscores the urgency of unraveling Cellular Hypoxia's multifaceted impact.

Biological markers, also known as biomarkers, are measurable indicators that can be used to assess the presence or progression of a biological process or condition. In the context of cell health and hypoxia, biological markers can help identify and monitor the effects of hypoxia on cells.

Some examples of biological markers related to hypoxia and cell health include:

• HIF-1: HIF-1 (hypoxia-inducible factor 1) is an endogenous hypoxia marker that is involved in cellular responses to low oxygen levels. It plays a crucial role in regulating genes that are involved in adaptation to hypoxia.
• EF5 (2-(2-nitro-1H–imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide): is an exogenous hypoxia marker that selectively identifies hypoxic cells. It is used to detect and quantify hypoxia in both live and fixed cells and can be measured using techniques such as immunohistochemistry and flow cytometry.
• HYOU1 (hypoxia upregulated 1): is an endogenous marker of hypoxia that is upregulated in response to low oxygen levels. It has been found to be a reliable marker of acute hypoxia and can be used as a diagnostic biomarker. HYOU1 expression can be measured using techniques such as quantitative PCR and western blotting
• CA IX: CA IX (carbonic anhydrase IX) is another endogenous hypoxia marker that is upregulated in response to hypoxic conditions. It is often used as a diagnostic biomarker for hypoxia in cancer cells.
• ERO1α: ERO1α (endoplasmic reticulum oxidoreductase 1 alpha) is a novel endogenous marker of hypoxia. It has been found to be a reliable marker of chronic hypoxia and can be used as a diagnostic biomarker.